Population health data rarely captures marginalized communities with enough precision to drive clinical practice—but when it does, the disparities revealed demand attention from anyone delivering or designing healthcare. A five-year pooled dataset from Rhode Island offers one of the more statistically robust state-level portraits of transgender adult health yet published, and the findings reframe how practitioners should think about screening and chronic disease burden in this population.
Drawing on 2020–2024 Rhode Island Behavioral Risk Factor Surveillance System (BRFSS) data, investigators identified that approximately 1% of Rhode Island adults identify as transgender. After adjusting for age and race and ethnicity, transgender adults showed more than three times the odds of reporting fair or poor overall health and frequent mental distress, nearly three times the odds of a documented depression history, and more than four times the odds of reporting any disability compared to their cisgender counterparts. Critically, healthcare access metrics—insurance coverage, having a primary care provider, and recent medical visits—were statistically similar between groups, isolating health outcome disparities from simple access barriers.
That access parity alongside pronounced outcome disparity is arguably the most clinically significant signal here. It suggests that mere contact with the healthcare system does not translate into equitable health for transgender patients—a pattern consistent with prior BRFSS analyses at national level and with research documenting minority stress as a chronic physiological burden. The depression and disability findings align with growing evidence that social marginalization, stigma-related chronic stress, and systemic discrimination produce measurable downstream effects on physical as well as mental health. Limitations worth noting include the telephone survey methodology, which may undersample the most socially isolated transgender individuals and thereby underestimate true disparities. The cross-sectional, observational design prevents causal inference. Nevertheless, the five-year pooled approach meaningfully strengthens statistical power for a low-prevalence subgroup—an incremental but genuine methodological advance. Clinicians should treat these findings as a prompt to audit whether culturally competent care protocols are actually reducing health gaps, not merely filling appointment slots.